Dokumentdetails
ID

oai:pubmedcentral.nih.gov:7732...

Thema
Articles
Autor
Seitz, Christian Casalino, Lorenzo Konecny, Robert Huber, Gary Amaro, Rommie E. McCammon, J. Andrew
Langue
en
Editor

The Biophysical Society

Kategorie

Biophysical Journal

Jahr

2020

Auflistungsdatum

29.11.2023

Schlüsselwörter
glycan primary ligand binding site influenza neuraminidase
Metrisch

Zusammenfassung

Influenza neuraminidase is an important drug target.

Glycans are present on neuraminidase and are generally considered to inhibit antibody binding via their glycan shield.

In this work, we studied the effect of glycans on the binding kinetics of antiviral drugs to the influenza neuraminidase.

We created all-atom in silico systems of influenza neuraminidase with experimentally derived glycoprofiles consisting of four systems with different glycan conformations and one system without glycans.

Using Brownian dynamics simulations, we observe a two- to eightfold decrease in the rate of ligand binding to the primary binding site of neuraminidase due to the presence of glycans.

These glycans are capable of covering much of the surface area of neuraminidase, and the ligand binding inhibition is derived from glycans sterically occluding the primary binding site on a neighboring monomer.

Our work also indicates that drugs preferentially bind to the primary binding site (i.e., the active site) over the secondary binding site, and we propose a binding mechanism illustrating this.

These results help illuminate the complex interplay between glycans and ligand binding on the influenza membrane protein neuraminidase.

Seitz, Christian,Casalino, Lorenzo,Konecny, Robert,Huber, Gary,Amaro, Rommie E.,McCammon, J. Andrew, 2020, Multiscale Simulations Examining Glycan Shield Effects on Drug Binding to Influenza Neuraminidase, The Biophysical Society

Dokumentieren

Öffnen Öffnen

Teilen

Quelle

Artikel empfohlen von ES/IODE AI